Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS10058996HBVENSG00000163631.19protein_codingALBNoNo213P02768
TVIS10059015HBVENSG00000163631.19protein_codingALBNoNo213P02768
TVIS10059003HBVENSG00000163631.19protein_codingALBNoNo213P02768
TVIS10060320HBVENSG00000163631.19protein_codingALBNoNo213P02768
TVIS10060335HBVENSG00000163631.19protein_codingALBNoNo213P02768
TVIS10060327HBVENSG00000163631.19protein_codingALBNoNo213P02768
TVIS10061253HBVENSG00000163631.19protein_codingALBNoNo213P02768
TVIS10059002HBVENSG00000163631.19protein_codingALBNoNo213P02768
TVIS10060328HBVENSG00000163631.19protein_codingALBNoNo213P02768
TVIS10060319HBVENSG00000163631.19protein_codingALBNoNo213P02768
TCGA Plot Options
Drug Information
GeneALB
DrugBank IDDB06713
Drug NameNorelgestromin
Target IDBE0000530
UniProt IDP02768
Regulation Type
PubMed IDs12586319
CitationsHammond GL, Abrams LS, Creasy GW, Natarajan J, Allen JG, Siiteri PK: Serum distribution of the major metabolites of norgestimate in relation to its pharmacological properties. Contraception. 2003 Feb;67(2):93-9.
GroupsApproved; Investigational
Direct ClassificationEstrane steroids
SMILES[H][C@@]12CC[C@@](O)(C#C)[C@@]1(CC)CC[C@]1([H])[C@@]3([H])CCC(C=C3CC[C@@]21[H])=NO
Pathways
PharmGKB
ChEMBLCHEMBL1200807